DrugPatentWatch Database Preview
EPIPEN JR. Drug Profile
When do Epipen Jr. patents expire, and when can generic versions of Epipen Jr. launch?
Epipen Jr. is a drug marketed by Mylan Speciality Lp and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in EPIPEN JR. is epinephrine. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
Summary for EPIPEN JR.
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 6 |
| Bulk Api Vendors: | 66 |
| Clinical Trials: | 7 |
| Patent Applications: | 4,369 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | EPIPEN JR. at DailyMed |
Pharmacology for EPIPEN JR.
| Ingredient-type | Catecholamines |
| Drug Class | alpha-Adrenergic Agonist beta-Adrenergic Agonist Catecholamine |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Medical Subject Heading (MeSH) Categories for EPIPEN JR.
Synonyms for EPIPEN JR.
| (-)-(R)-Epinephrine |
| (-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol |
| (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol |
| (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol |
| (-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol |
| (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol |
| (-)-Adrenalin |
| (-)-Adrenaline |
| (-)-Epinephrine |
| (-)-Epinephrine, >=97.0% (NT) |
| (-)-Epinephrine;L-Adrenaline;(-)-Adrenalin |
| (-)-R-Epinephrine |
| (+/-)-3,4-Dihydroxy-alpha-(methylaminomethyl)benzyl alcohol |
| (+/-)-Adrenalin |
| (R)-(-)-3,4-Dihydroxy-alpha-(methylaminomethyl)benzyl alcohol |
| (R)-(-)-Adnephrine |
| (R)-(-)-Adrenaline |
| (R)-(-)-Epinephrine |
| (R)-(-)-Epirenamine |
| (r)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol |
| (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol |
| (R)-Adrenaline |
| (R)-Epinephrine |
| 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol |
| 1-Adrenalin |
| 1-Epinephrine |
| 1,2-Benzenediol, 4-((1R)-1-hydroxy-2-(methylamino)ethyl)- |
| 1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)- |
| 1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)- |
| 1,2-Benzenediol, 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]- |
| 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)- |
| 1401-EP2270011A1 |
| 1401-EP2298735A1 |
| 1401-EP2301934A1 |
| 1401-EP2305677A1 |
| 1401-EP2308562A2 |
| 1401-EP2308861A1 |
| 1401-EP2311464A1 |
| 1401-EP2311823A1 |
| 1401-EP2314571A2 |
| 2,3-bis(oxidanyl)butanedioic acid;4-[(1R)-2-(methylamino)-1-oxidanyl-ethyl]benzene-1,2-diol |
| 2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol |
| 204017-EP2277867A2 |
| 204017-EP2280003A2 |
| 3,4-Dihydroxy-.alpha.-((methylamino)methyl)benzyl alcohol |
| 3,4-Dihydroxy-alpha-(methylaminomethyl)benzyl alcohol |
| 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol |
| 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol |
| 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol |
| 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol |
| 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]pyrocatechol;tartaric acid |
| 4-[(1R)-1-hydroxy-2-methylamino-ethyl]benzene-1,2-diol |
| 4-[(1R)-1-hydroxy-2-methylaminoethyl]benzene-1,2-diol |
| 4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol |
| 4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol # |
| 4,5-beta-trihydroxy-N-methylphenethylamine |
| 51-43-4 |
| 51-43-4 (FREE BASE) |
| 51028-73-0 |
| 6367-EP2272841A1 |
| 6367-EP2277861A1 |
| 6367-EP2301934A1 |
| 6367-EP2301936A1 |
| 6367-EP2314571A2 |
| 91382-EP2284149A1 |
| 91382-EP2305636A1 |
| A0173 |
| AB00573227_14 |
| AB00573227_15 |
| AB00573227-11 |
| AB00573227-12 |
| AB00573227-13 |
| AB2000623 |
| AC-13188 |
| AC1L1L7B |
| Adnephrine |
| ADR ADRENALINE |
| Adrenaclick |
| Adrenal |
| Adrenalin |
| Adrenalin (TN) |
| Adrenalin chloride |
| Adrenalin in Oil |
| Adrenalin-Medihaler |
| Adrenalina |
| Adrenalina [DCIT] |
| adrenaline |
| Adrenaline (JP15) |
| Adrenaline (JP17) |
| Adrenaline (L-Adrenaline) |
| Adrenaline with impurity F, European Pharmacopoeia (EP) Reference Standard |
| Adrenaline, European Pharmacopoeia (EP) Reference Standard |
| Adrenaline/Epinephrine |
| Adrenalinum |
| Adrenamine |
| Adrenan |
| Adrenapax |
| Adrenasol |
| Adrenatrate |
| Adrenine |
| Adrenodis |
| Adrenohorma |
| Adrenosan |
| Adrenutol |
| Adrin |
| Adrine |
| ADROP |
| AI3-19015 |
| AJ-08814 |
| AKOS024283500 |
| ALE |
| AN-15872 |
| Ana-Guard |
| Ana-Kit |
| Antiasthmatique |
| AS-13813 |
| Asmatane Mist |
| Asthma meter mist |
| Asthma-nefrin |
| Asthmahaler Mist |
| Asthmanefrin |
| Astmahalin |
| Astminhal |
| Auvi-q |
| Auvi-q (TN) |
| Auvi-Q auto-injector |
| Balmadren |
| BC204174 |
| BDBM44818 |
| BDBM50029050 |
| Benzyl alcohol, 3,4-dihydroxy-.alpha.-[(methylamino)methyl]-, (-)- |
| Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)- |
| Bernarenin |
| BIDD:GT0119 |
| Biorenine |
| bmse000316 |
| Bosmin |
| Brevirenin |
| Bronkaid |
| Bronkaid Mist |
| Bronkaid Suspension Mist |
| Bupivacaine Hcl and Epinephrine |
| C00788 |
| C9H13NO3 |
| CAS-51-43-4 |
| CCG-204593 |
| CCRIS 4812 |
| CHEBI:28918 |
| Chelafrin |
| CHEMBL679 |
| cid_6852374 |
| Citanest Forte |
| Citanest Forte (Salt/Mix) |
| component of E-Pilo (Salt/Mix) |
| Corisol |
| CS-2558 |
| CTK4J3509 |
| d-Adrenaline |
| D-Epifrin |
| D-Epinephrine |
| D00095 |
| D29A657 |
| DB00668 |
| Drenamist |
| DSSTox_CID_2986 |
| DSSTox_GSID_22986 |
| DSSTox_RID_76819 |
| DTXSID5022986 |
| Dylephrin |
| Dyspne-Inhal |
| E4250_SIGMA |
| EINECS 200-098-7 |
| EPI E Z PEN JR |
| Epi EZ Pen Jr |
| Epifrin |
| Epiglaufrin |
| Epinefrin |
| Epinefrin [Czech] |
| Epinefrina |
| Epinefrina [INN-Spanish] |
| Epinephran |
| epinephrine |
| EPINEPHRINE (SEE ALSO: EPINEPHRINE HYDROCHLORIDE (CAS 55-31-2)) |
| Epinephrine (USP) |
| Epinephrine (USP/INN) |
| Epinephrine [USAN:INN:JAN] |
| Epinephrine [USP:INN:BAN:JAN] |
| Epinephrine HCl |
| Epinephrine hydrochloride |
| Epinephrinum |
| Epinephrinum [INN-Latin] |
| Epipen |
| Epipen (TN) |
| Epipen Auto-Injector |
| EPIPEN E Z PEN |
| Epipen EZ Pen |
| EPIPEN JR |
| Epipen Jr. Auto-Injector |
| Epirenamine |
| Epirenan |
| Epirenin |
| Epitrate |
| Epitrate (Salt/Mix) |
| Eppy |
| Esphygmogenina |
| Exadri |
| Exadrin |
| Glaucon |
| Glaucosan |
| Glauposine |
| Glycirenan |
| GTPL479 |
| Haemostasin |
| Haemostatin |
| Hektalin |
| Hemisine |
| Hemostasin |
| Hemostatin |
| HSCI1_000215 |
| HSDB 4289 |
| HY-B0447B |
| Hypernephrin |
| Hyporenin |
| Intranefrin |
| Iontocaine |
| IOP |
| Isoptoepinal |
| J10365 |
| Kidoline |
| l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol |
| l-Adrenalin |
| l-Adrenaline |
| L-Adrenaline (Epinephrine) |
| L-Adrenaline Base |
| l-adrenaline,(-)adrenaline,l-epinephrine,l-3,4-dihydroxy-alpha-(methylaminomethyl)benzyl alcohol,l-1-methyl aminoethanol catechol |
| L-Epinehphrine |
| l-Epinephine |
| L-epinephrine |
| l-Epinephrine (synthetic) |
| l-Epirenamine |
| l-Methylaminoethanolcatechol |
| L(-)-Epinephrine |
| L926 |
| Levo-Methylaminoethanolcatechol |
| Levoadrenaline |
| Levoepinephrine |
| Levorenen |
| Levorenin |
| Levorenine |
| Levoreninum |
| Lopac-E-4642 |
| LS-156 |
| Lyodrin |
| Lyophrin |
| MCULE-9462717294 |
| Medihaler-Epi |
| Metanephrin |
| Methylaminoethanolcatechol |
| Methylarterenol |
| MFCD00002204 |
| MFCD00063027 |
| Micronefrin |
| MolPort-002-051-368 |
| Mucidrina |
| Myosthenine |
| Mytrate |
| NCGC00015417-01 |
| NCGC00142615-01 |
| NCGC00142615-03 |
| NCGC00142615-04 |
| NCGC00142615-05 |
| NCGC00142615-06 |
| NCGC00142615-07 |
| NCGC00142615-08 |
| NCGC00142615-09 |
| nchembio747-comp9 |
| NE58416 |
| Nephridine |
| Nieraline |
| NSC 62786 |
| NSC62786 |
| OR023601 |
| OR154878 |
| OR276267 |
| OR349940 |
| Paranephrin |
| PDSP1_001120 |
| PDSP2_001104 |
| Primatene |
| Primatene Mist |
| Q-200601 |
| R-(-)-Epinephrine |
| R-Adrenaline |
| RCRA waste no. P042 |
| Rcra waste number P042 |
| Renagladin |
| Renaglandin |
| Renaglandulin |
| Renaleptine |
| Renalina |
| Renoform |
| Renostypricin |
| Renostypticin |
| Renostyptin |
| s2522 |
| SBB012384 |
| SCHEMBL3814 |
| Scurenaline |
| Septocaine |
| Simplene |
| Sindrenina |
| SMP1_000227 |
| Soladren |
| Sphygmogenin |
| SR-01000075267-8 |
| ST069368 |
| Stryptirenal |
| Styptirenal |
| Supracapsulin |
| Supradin |
| Supranefran |
| Supranephrane |
| Supranephrine |
| Supranol |
| Suprarenaline |
| Suprarenin |
| Suprel |
| Surenine |
| Surrenine |
| Sus-Phrine |
| SUS-PHRINE SULFITE-FREE |
| Susphrine |
| Symjepi |
| Sympathin I |
| Takamina |
| Takamine |
| Tokamina |
| Tonogen |
| Tox21_111562 |
| Tox21_111562_1 |
| TR-033467 |
| Twinject |
| Twinject 0.15 |
| Twinject 0.3 |
| Twinject 0.30 |
| UCTWMZQNUQWSLP-VIFPVBQESA-N |
| UNII-GR0L9S3J0F component UCTWMZQNUQWSLP-VIFPVBQESA-N |
| UNII-YKH834O4BH |
| Vaponefrin |
| Vasoconstrictine |
| Vasoconstrictor |
| Vasodrine |
| Vasoton |
| Vasotonin |
| YKH834O4BH |
| Z2686405805 |
| ZINC39089 |
US Patents and Regulatory Information for EPIPEN JR.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | EPIPEN JR. | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 019430-002 | Dec 22, 1987 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Mylan Speciality Lp | EPIPEN JR. | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 019430-002 | Dec 22, 1987 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Mylan Speciality Lp | EPIPEN JR. | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 019430-002 | Dec 22, 1987 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for EPIPEN JR.
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Injection (Auto-injector) | 0.15 mg/0.3 mL and 0.3 mg/0.3 mL | ➤ Subscribe | ➤ Sign Up |
